ERBB2 and cancer: Consistently, Montgomery et al. reported that antibodies induced by HER2 peptide vaccination in patients are capable of inhibiting HER2 phosphorylation and downstream activation of ERK leading to the subsequent suppression of cancer cell proliferation [42].